Schneider G - Search Results

1

Cross talk between stimulated NF-kappaB and the tumor suppressor p53.

Schneider G, Henrich A, Greiner G, Wolf V, Lovas A, Wieczorek M, Wagner T, Reichardt S, von Werder A, Schmid RM, Weih F, Heinzel T, Saur D, Krämer OH. Schneider G, et al. Oncogene. 2010 May 13;29(19):2795-806. doi: 10.1038/onc.2010.46. Epub 2010 Mar 1. Oncogene. 2010. PMID: 20190799

2

[Pancreatic carcinogenesis. Clinical implications].

Schneider G, Lersch C, Schmid RM. Schneider G, et al. Chirurg. 2003 Mar;74(3):165-70. doi: 10.1007/s00104-003-0618-6. Chirurg. 2003. PMID: 12647072 German.

3

[Pathogenesis of the ductal pancreatic adenocarcinoma: implications for future therapies?].

Schneider G, Schmid RM. Schneider G, et al. Internist (Berl). 2005 Feb;46(2):157-65. doi: 10.1007/s00108-004-1330-4. Internist (Berl). 2005. PMID: 15655682 Review. German.

4

HDAC3 is linked to cell cycle machinery in MiaPaCa2 cells by regulating transcription of skp2.

Schneider G, Reichert M, Saur D, Hamacher R, Fritsch R, Schmid RM. Schneider G, et al. Cell Prolif. 2007 Aug;40(4):522-31. doi: 10.1111/j.1365-2184.2007.00454.x. Cell Prolif. 2007. PMID: 17635519 Free PMC article.

5

HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA.

Fritsche P, Seidler B, Schüler S, Schnieke A, Göttlicher M, Schmid RM, Saur D, Schneider G. Fritsche P, et al. Among authors: schneider g. Gut. 2009 Oct;58(10):1399-409. doi: 10.1136/gut.2009.180711. Epub 2009 Jun 14. Gut. 2009. PMID: 19528037

6

Bispectral index monitoring of midazolam and propofol sedation during endoscopic retrograde cholangiopancreatography: a randomized clinical trial (the EndoBIS study).

von Delius S, Salletmaier H, Meining A, Wagenpfeil S, Saur D, Bajbouj M, Schneider G, Schmid RM, Huber W. von Delius S, et al. Among authors: schneider g. Endoscopy. 2012 Mar;44(3):258-64. doi: 10.1055/s-0031-1291485. Epub 2012 Jan 19. Endoscopy. 2012. PMID: 22261747 Clinical Trial.

7

Oncogenic KRAS signalling in pancreatic cancer.

Eser S, Schnieke A, Schneider G, Saur D. Eser S, et al. Among authors: schneider g. Br J Cancer. 2014 Aug 26;111(5):817-22. doi: 10.1038/bjc.2014.215. Epub 2014 Apr 22. Br J Cancer. 2014. PMID: 24755884 Free PMC article. Review.

8

MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies.

Hessmann E, Schneider G, Ellenrieder V, Siveke JT. Hessmann E, et al. Among authors: schneider g. Oncogene. 2016 Mar 31;35(13):1609-18. doi: 10.1038/onc.2015.216. Epub 2015 Jun 29. Oncogene. 2016. PMID: 26119937 Review.

9

Kras(G12D) induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells.

Diersch S, Wirth M, Schneeweis C, Jörs S, Geisler F, Siveke JT, Rad R, Schmid RM, Saur D, Rustgi AK, Reichert M, Schneider G. Diersch S, et al. Among authors: schneider g. Oncogene. 2016 Jul 21;35(29):3880-6. doi: 10.1038/onc.2015.437. Epub 2015 Nov 23. Oncogene. 2016. PMID: 26592448 Free PMC article.

10

HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancer.

Stojanovic N, Hassan Z, Wirth M, Wenzel P, Beyer M, Schäfer C, Brand P, Kroemer A, Stauber RH, Schmid RM, Arlt A, Sellmer A, Mahboobi S, Rad R, Reichert M, Saur D, Krämer OH, Schneider G. Stojanovic N, et al. Among authors: schneider g. Oncogene. 2017 Mar 30;36(13):1804-1815. doi: 10.1038/onc.2016.344. Epub 2016 Oct 10. Oncogene. 2017. PMID: 27721407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,000 results

Search Page

Filters